BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25854863)

  • 1. Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel.
    Kapplinger JD; Tseng AS; Salisbury BA; Tester DJ; Callis TE; Alders M; Wilde AA; Ackerman MJ
    J Cardiovasc Transl Res; 2015 Apr; 8(3):187-97. PubMed ID: 25854863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.
    Clemens DJ; Lentino AR; Kapplinger JD; Ye D; Zhou W; Tester DJ; Ackerman MJ
    Heart Rhythm; 2018 Apr; 15(4):555-561. PubMed ID: 29197658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization of type 1 long QT syndrome caused by C-terminus Kv7.1 variants.
    Kashiwa A; Itoh H; Makiyama T; Wada Y; Ozawa J; Kato K; Fukuyama M; Nakajima T; Ohno S; Horie M
    Heart Rhythm; 2024 Jul; 21(7):1113-1120. PubMed ID: 38367891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.
    Spätjens RL; Bébarová M; Seyen SR; Lentink V; Jongbloed RJ; Arens YH; Heijman J; Volders PG
    Cardiovasc Res; 2014 Oct; 104(1):216-25. PubMed ID: 25139741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
    Bartos DC; Giudicessi JR; Tester DJ; Ackerman MJ; Ohno S; Horie M; Gollob MH; Burgess DE; Delisle BP
    Heart Rhythm; 2014 Mar; 11(3):459-68. PubMed ID: 24269949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.
    Chen XM; Guo K; Li H; Lu QF; Yang C; Yu Y; Hou JW; Fei YD; Sun J; Wang J; Li YX; Li YG
    Heart Vessels; 2019 Jan; 34(1):177-188. PubMed ID: 30008122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Low-Risk Adult Congenital LQTS Patients.
    Zhang C; Kutyifa V; McNitt S; Zareba W; Goldenberg I; Moss AJ
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):853-858. PubMed ID: 25872798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
    Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
    J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.
    Burgess DE; Bartos DC; Reloj AR; Campbell KS; Johnson JN; Tester DJ; Ackerman MJ; Fressart V; Denjoy I; Guicheney P; Moss AJ; Ohno S; Horie M; Delisle BP
    Biochemistry; 2012 Nov; 51(45):9076-85. PubMed ID: 23092362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
    Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic mechanisms for long QT syndrome type 1 revealed by single-channel analysis of I(Ks) with S3 domain mutations in KCNQ1.
    Eldstrom J; Wang Z; Werry D; Wong N; Fedida D
    Heart Rhythm; 2015 Feb; 12(2):386-94. PubMed ID: 25444851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.
    Odening KE
    Cardiovasc Res; 2024 May; 120(7):673-674. PubMed ID: 38630861
    [No Abstract]   [Full Text] [Related]  

  • 16. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
    Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
    Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.
    Bartos DC; Duchatelet S; Burgess DE; Klug D; Denjoy I; Peat R; Lupoglazoff JM; Fressart V; Berthet M; Ackerman MJ; January CT; Guicheney P; Delisle BP
    Heart Rhythm; 2011 Jan; 8(1):48-55. PubMed ID: 20850564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.
    Giudicessi JR; Kapplinger JD; Tester DJ; Alders M; Salisbury BA; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2012 Oct; 5(5):519-28. PubMed ID: 22949429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the interpretation of genetic observations in KCNQ1 in unselected populations: relevance to secondary findings.
    Novelli V; Faultless T; Cerrone M; Care M; Manzoni M; Bober SL; Adler A; De-Giorgio F; Spears D; Gollob MH
    Europace; 2023 Nov; 25(11):. PubMed ID: 37897496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.
    Laksman ZW; Hamilton RM; Chockalingam P; Ballantyne E; Stephenson EA; Gross GJ; Gula LJ; Klein GJ; Wilde AA; Krahn AD
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1015-20. PubMed ID: 23691991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.